Top Markets
Coin of the day
Avisa Diagnostics Inc. Avisa Diagnostics Inc.

Avisa Diagnostics Inc.

AVBT
Rank in Stocks #40597
Avisa Diagnostics Inc., a clinical-stage medical device company based in Santa... Avisa Diagnostics Inc., a clinical-stage medical device company based in Santa Fe, New Mexico, is dedicated to developing the Avisa BreathTest. This innovative drug/device biomarker technology platform is designed for the ultra-rapid identification of virulent bacterial pathogens and the subsequent monitoring of bacterial load. The system works by analyzing a patient's breath after they have inhaled or ingested Avisa's proprietary drug substrates. The company has already established clinical proof-of-concept through trials in conditions such as cystic fibrosis, tuberculosis, and community-acquired pneumonia, and is now concentrating on pivotal trials for Post-COVID-19 bronchiectasis and ventilator-associated pneumonia.
Share Price
$0.0333321
Last synced: 2023-05-23
Market Cap
$114.40K
Change (1 day)
-0.04%
Change (1 year)
0.00%
Country
US
Trade Avisa Diagnostics Inc. (AVBT)

Category

Operating Margin for Avisa Diagnostics Inc. (AVBT)
Operating Margin as of 2026 TTM: 0.00%
According to Avisa Diagnostics Inc. latest financial reports and stock price the company's current Operating Margin (TTM) is 0.00%. At the end of 2026 the company had an Operating Margin of 0.00%.
Operating Margin history for Avisa Diagnostics Inc. from 2026 to 2026
Operating Margin at the end of each year
Year Operating Margin Change
Not enough data for the provided dates.
Operating Margin for similar companies or competitors
Company Operating Margin Operating Margin Difference Country
17.03% -
US
22.03% -
US
17.86% -
IE
21.46% -
US
28.09% -
US
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.